Found 139 clinical trials
PCSK9i in AAA123
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 18 Mar, 2025
- 2 locations
Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States
In this program, the investigators will develop novel multimodal neural-behavioral-physiological monitoring tools (software and hardware), and machine learning models for mental states within social processes and beyond. The tools consist of a multimodal skin-like wearable sensor for physiological and biochemical sensing; a conversational virtual human platform to evoke naturalistic social …
- 0 views
- 19 Aug, 2025
- 2 locations
Regression testing of PS ( DO NOT TOUCH )
Regression testing of PS ( DO NOT TOUCH )
- 0 views
- 25 Mar, 2026
- 1 location
Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE) (PHRASE-2024)
This study is a multicentric randomized controlled trial evaluating the effectiveness of digital technology, specifically a smartphone with integrated VR-and AR-based intervention, for at-home rehabilitation after stroke. The study focuses on combined motor and cognitive training for patients in the late subacute and chronic phases post-stroke. The intervention is provided …
- 0 views
- 02 Apr, 2026
- 1 location
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission - Josh McVoy
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
- 0 views
- 24 Apr, 2026
- 2 locations
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (EXCALIBER-RRMM)
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
- 0 views
- 20 May, 2026
- 1 location